Sigma Labs, Inc. Releases Version 3.5 of Its Proprietary In-Process Quality Assurance Software: The Frontiersman™
SANTA FE, N.M., March 31, 2011 /PRNewswire/ -- SIGMA LABS, INC. (OTC Bulletin Board: SGLB) today release of Version 3.5 of its In Process Quality Assurance (IPQA) software, The Frontiersman™. This latest release is a vital part of Sigma Labs' product offering and includes enhanced analysis and reporting functions. IPQA enables companies to continuously monitor their manufacturing processes allowing them to identify flaws early on and eliminating costly final inspections.
Mark Cola, President of Sigma Labs, states: "Manufacturing defects are just like external symptoms of an internal disease – they indicate that something is wrong inside the process or system. Just like advanced medical monitoring can detect and classify the causes of diseases in the body by observing internal body functions, our IPQA systems observe the inner workings of a manufacturing process in real-time on the machine tool. We can help detect problems before they become defects, saving money and time in scrap or rework." Mr. Cola continued: "Our system, potentially, has widespread applications throughout industry, in general."
About Sigma Labs, Inc.
Sigma Labs, Inc. comprises leading scientists and engineers with over 75 years of combined industrial R&D experience from Los Alamos National Laboratory and has become developer of manufacturing and materials technologies and an important R&D provider to first-tier integrators including Boeing, Honeywell, and Pratt & Whitney as well as to commercial firms within the United States and internationally. Sigma Labs, Inc. currently has contracts with both the federal Government and private industry to develop technologies from their conception through the design, building, and testing of prototype systems. Sigma Labs, Inc. is aggressively designing and developing innovative sensing, software products, materials technologies and other unique manufacturing quality assurance solutions for the federal Government and our commercial clients.
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission, including our Report on Form 8-K that was filed in connection with the transaction we recently completed with B6 Sigma. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Sigma Labs, Inc.
Released March 31, 2011